FDA 483 - LifeShare Blood Center - September 01, 2022

An FDA inspection of LifeShare Blood Center in Lafayette, LA, a donor collection facility, identified one observation. The firm failed to prepare and maintain written reports of investigations for adverse donor reactions. Specifically, a donor's vasovagal reaction during a whole blood collection was not documented as required by the facility's standard operating procedure.